Form 4: Oragenics Inc. Director Bruce A. Cassidy Sr. Awarded Options

Director Bruce A. Cassidy Sr. received options to purchase 45,000 shares of Oragenics Inc. common stock.

Summary

• Bruce A. Cassidy Sr., a director of Oragenics Inc. (OGEN), was granted options to purchase 45,000 shares of the company's common stock on September 19, 2024.
• The options were awarded under the company's 2021 Equity Incentive Plan, as amended, as part of the non-employee director compensation program.
• The exercise price of the options is $0.48, which is the closing price of Oragenics' stock on the grant date.
• The options vest immediately and expire on September 19, 2034.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of an option grant to a director. It's neutral in tone and doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Positives

• The immediate vesting of the options provides an incentive for the director to contribute to the company's success.
• The grant aligns the director's interests with those of the shareholders.

Industry Context

Option grants to directors are a common practice in publicly traded companies as part of their compensation packages, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary widely across the biotechnology industry depending on company size, stage of development, and performance.
• Comparing Oragenics' director compensation to similar-sized biotech companies would provide a better understanding of whether this grant is in line with industry norms.
• Companies like Generex Biotechnology or Mustang Bio could be considered for comparison, focusing on their director compensation structures and equity grants.

Stakeholder Impact

• The option grant could potentially incentivize the director to work towards increasing shareholder value.
• The grant has a dilutive effect on existing shareholders, although the impact is likely minimal given the size of the grant.

Key Dates

Keywords

Oragenics Inc, Director, Options, Equity Incentive Plan, Compensation, OGEN, Bruce A. Cassidy Sr., Stock Options